Zusammenfassung
Ein wesentliches Ziel moderner Psychiatrie besteht darin, die biologischen Mechanismen mentaler Funktion und Dysfunktion besser zu verstehen. Besonderes Interesse gilt dabei der Erforschung der neuronalen Netzwerke, die es dem Individuum erlauben die Umgebung wahrzunehmen, Gedächtnisspuren zu bilden und abzurufen sowie adäquate Handlungsstrategien zu entwickeln und umzusetzen. Ein besonderer Fokus in der Psychiatrie liegt auch in der Erforschung der biologischen Basis des emotionalen Erlebens: Fragen wie »Auf welche Weise beeinflussen Emotionen unser Denken?« oder »In welchem Zusammenhang steht die Regulation von Gefühlen, Gedanken und Handeln mit der Entstehung einer Angsterkrankung, Depression, Manie oder Schizophrenie?« gilt es dabei zu beantworten. Im Gegensatz zu den klassischen Anwendungsfeldern der Neuropsychologie bei neurologischen Störungsbildern entziehen sich die beobachteten Verhaltens- und Erlebensauffälligkeiten der Neuropsychiatrie jedoch (noch) häufig einer genauen Definierbarkeit des zugrunde liegenden Substrates. Gerade in diesem Forschungsfeld kommt der bildgebenden Grundlagenforschung deshalb eine besondere Funktion im Zuge der Erkenntnisgewinnung zu.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F (2000) Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 47: 305–313
Barch DM, Carter CS, Braver TS, Sabb FW, MacDonald A, 3rd, Noll DC, Cohen JD (2001) Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Arch Gen Psychiatry 58: 280–288
Barber R, Ballard C, McKeith IG, Gholkar A, O’Brien JT (2000) MRI volumetric study of dementia with Lewy bodies: a comparison with AD and vascular dementia. Neurology 54: 1304–1309
Baxter LR Jr, Schwartz JM, Bergman KS et al. (1992) Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 49: 681–689
Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, Weinberger DR (2001) The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 49: 39–46
Birbaumer N, Grodd W, Diedrich O, Klose U, Erb M, Lotze M, Schneider F, Weiss U, Flor H (1998) fMRI reveals amygdala activation to human faces in social phobics. Neuroreport 9: 1223–1226
Braus DF, Ende G, Weber-Fahr W et al. (1999) Antipsychotic drug effects on motor activation measured by functional magnetic resonance imaging in schizophrenic patients. Schizophr Res 39: 19–29
Braus DF, Ende G, Tost H et al. (2000) Funktionelle Kernspintomographie und Schizophrenie: Medikamenteneffekte, methodische Grenzen und Perspektiven. Nervenheilkunde 3: 121–128
Braus DF, Ende G, Weber-Fahr W, Demirakca T, Henn FA (2001a) Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 34: 251–253
Braus DF, Tost H, Hirsch JG, Gass A (2001b) Diffusions-TensorBildgebung ( DTI) und funktionelle Magnetresonanztomographie (fMRI) erweitern das Methodenspektrum in der psychiatrischen Forschung. Nervenarzt 72: 384–390
Braus DF, Brassen S, Demirakca T, Weimer E, Ruf M (2002a) Psychopharmakaeffekte und moderne Kernspintomographie: Stand der Diskussion, Möglichkeiten und Grenzen. Nervenheilkunde 21: 363–371
Braus DF, Weber-Fahr W, Tost H, Ruf M, Henn FA (2002b) Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. Arch Gen Psychiatry 59: 696–701
Breiter HC, Etcoff NL, Whalen PJ et al. (1996) Response and habituation of the human amygdala during visual processing of facial expression. Neuron 17: 875–887
Breiter HC, Rauch SL (1996) Functional MRI and the Study of OCD: from symptom provocation to cognitive-behavioral probes of cortico-striatal systems and the amygdala. Neuroimage 4: 5127–5138
Bremner JD, Staib LH, Kaloupek D, Southwick SM, Soufer R, Charney DS (1999) Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry 45: 806–816
Büchel C, Dolan RJ, Armony JL, Friston KJ (1999) Amygdalahippocampal involvement in human aversive trace conditioning revealed through event-related functional magnetic resonance imaging. J Neurosci 19: 10869–10876
Buchsbaum MS, Tang CY, Peled Set al. (1998) MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport 9: 425–430
Chacko RC, Corbin MA, Harper RG (2000) Acquired obsessive-compulsive disorder associated with basal ganglia lesions. J Neuropsychiatry Clin Neurosci 12: 269–272
Chua P, Dolan RJ (2000) The neurobiology of anxiety and anxiety-related disorders: A functional neuroimaging perspective. In: Mazziota JC, Toga AW, Frackowiak RSJ (eds) Brain mapping–the disorders. Academic Press, San Diego, pp 509–522
Crow TJ, Colter N, Frith CD, Johnstone EC, Owens DG (1989) Developmental arrest of cerebral asymmetries in early onset schizophrenia. Psychiatry Res 29: 247–253
Curtis VA, Bullmore ET, Morris RG et al. (1999) Attenuated frontal activation in schizophrenia may be task dependent. Schizophr Res 37: 35–44
Davidson RJ, Pizzagalli D, Nitschke JB, Putnam K (2002) Depression: perspectives from affective neuroscience. Annu Rev Psychol 53: 545–574
Dierks T, Linden DE, Jandl M, Formisano E, Goebel R, Lanfermann H, Singer W (1999) Activation of Heschl’s gyrus during auditory hallucinations. Neuron 22: 615–621
Drevets WC (2000) Neuroimaging studies of mood disorders. Biol Psychiatry 48: 813–829
Egan MF, Goldberg TE, Kolachana BS et al. (2001) Effect of COMT Val108t158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917–6922
Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA (2000) The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 57: 937–943
Estilaei MR, Matson GB, Payne GS, Leach MO, Fein G, Meyerhoff DJ (2001) Effects of abstinence from alcohol on the broad phospholipid signal in human brain: an in vivo 31P magnetic resonance spectroscopy study. Alcohol Clin Exp Res 25: 1213–1220
Foong J, Maier M, Clark CA, Barker GJ, Miller DH, Ron MA (2000) Neuropathological abnormalities of the corpus callosum in schizophrenia: a diffusion tensor imaging study. J Neurol Neurosurg Psychiatry 68: 242–244
Frackowiak RS, Friston KJ, Frith CD, Dolan RJ, Maziotta JC (1997) Human brain function. Academic Press, San Diego
Gadian DD (1995) NMR and its application to living systems. Oxford University Press, Oxford
Goldman-Rakic PS (1988) Topography of cognition: parallel distributed networks in primate association cortex. Annu Rev Neurosci 11: 137–156
Hariri AR, Mattay VS, Tessitore A et al. (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297: 400–403
Hanyu H, Sakurai H, Iwamoto T, Takasaki M, Shindo H, Abe K (1998) Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer’s disease. J Neurol Sci 156: 195–200
Hanyu H, Asano T, Sakurai H et al. (1999) Diffusion-weighted and magnetization transfer imaging of the corpus callo-sum in Alzheimer’s disease. J Neurol Sci 167: 37–44
Hariri AR, Mattay VS, Tessitore A et al. (2002) Serotonin transporter genetic variation and the response of the human amygdala. Science 297: 400–403.
Diese aktuelle Veröffentlichung der Arbeitsgruppe um Weinberger dokumentiert das Bestreben der modernen Neurowissenschaften, eine integrierte Sicht auf psychopathologische Symptome, ihre hirnfunktionellen Korrelate und zugrunde liegenden genetischen Vulnerabilitäten zu erlangen. So gelang es den Autoren, einen Zusammenhang zwischen Individuen mit einem bestimmten genetischen Polymorphismus des Serotonintransportergens (SLC6A4) und einer verstärkten Amygdalaaktivierung auf angstauslösende Stimuli herzustellen. Dieser Befund spricht dafür, dass mit der Kombination von Molekulargenetik, Neuropsychologie und Bildgebung Zusammenhänge zwischen Genen und Hirnfunktion untersuchbar werden. Es zeigte sich dabei, dass wesentliche Aspekte der Funktion und Dysfunktion emotionalen Erlebens nicht zuletzt auch durch genetische Faktoren angestoßen werden können und mit nachweisbaren hirnfunktionellen Veränderungen einhergehen.
Henn FA, Braus DF (1999) Structural neuroimaging in schizophrenia. An integrative view of neuromorphology. Eur Arch Psychiatry Clin Neurosci 249: 48–56
Hommer DW (1999) Functional imaging of craving. Alcohol Res Health 23: 187–196
Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T (1999) Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA 96: 13432–13437
Hsu YY, Du AT, Schuff N, Weiner MW (2001) Magnetic resonance imaging and magnetic resonance spectroscopy in dementias. J Geriatr Psychiatry Neurol 14: 145–166
Johnstone EC, Crow TJ, Frith CD, Husband J, Kreel L (1976) Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 2: 924–926
Klingberg T, Hedehus M, Temple E, Salz T, Gabrieli JD, Moseley ME, Poldrack RA (2000) Microstructure of temporo-parietal white matter as a basis for reading ability: evidence from diffusion tensor magnetic resonance imaging. Neuron 25: 493–500
LaBar KS, Gatenby JC, Gore IC, LeDoux JE, Phelps EA (1998) Human amygdala activation during conditioned fear acquisition and extinction: a mixed-trial fMRI study. Neuron 20: 937–945
Lennox BR, Park SB, Medley I, Morris PG, Jones PB (2000) The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Res 100: 13–20
Liberzon I, Taylor SF, Amdur R et al. (1999) Brain activation in PTSD in response to trauma-related stimuli. Biol Psychiatry 45: 817–826
Liddle PF (1995) Inner connections within domain of dementia praecox: role of supervisory mental processes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 245: 210–215
Liddle PF, Barnes TR (1990) Syndromes of chronic schizophrenia. Br J Psychiatry 157: 558–561
Lim KO, Hedehus M, Moseley M, de Crespigny A, Sullivan EV, Pfefferbaum A (1999) Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. Arch Gen Psychiatry 56: 367–374
Manoach DS, Press DZ, Thangaraj Vet al. (1999) Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biol Psychiatry 45: 1128–1137
Mayberg HS, Liotti M, Brannan SK et al. (1999) Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am 1 Psychiatry 156: 675–682
Mayberg HS, Silva JA, Brannan SK, Tekell JL, Mahurin RK, McGinnis S, Jerabek PA (2002) The functional neuroanatomy of the placebo effect. Am J Psychiatry 159: 728–737
Merzenich M (1998) Long-term change of mind. Science 282: 1062–1063
Modell JG, Mountz JM, Beresford TP (1990) Basal ganglia/limbic striatal and thalamocortical involvement in craving and loss of control in alcoholism. 1 Neuropsychiatry Clin Neurosci 2: 123–144
Morris JS, Frith CD, Perrett DI, Rowland D, Young AW, Calder AJ, Dolan RJ (1996) A differential neural response in the human amygdala to fearful and happy facial expressions. Nature 383: 812–815
Murray RM, O’Callaghan E, Castle DJ, Lewis SW (1992) A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 18: 319–332
Northoff G, Braus DF, Sartorius A et al. (1999) Reduced activation and altered laterality in two neuroleptic-naive catatonic patients during a motor task in functional MRI. Psychol Med 29: 997–1002
Nestler EJ, Barrot M, DiLeone RJ, Eisch Ai, Gold Si, Monteggia LM (2002) Neurobiology of depression. Neuron 34: 13–25
Ogawa S, Lee TM (1990) Magnetic resonance imaging of blood vessels at high fields: in vivo and in vitro measurements and image simulation. Magn Reson Med 16: 9–18
Okamura N, Arai H, Higuchi M, Tashiro M, Matsui T, Hu XS, Takeda A, Itoh M, Sasaki H (2001) 18FDG-PET study in dementia with Lewy bodies and Alzheimer’s disease. Prog Neuropsychopharmacol Biol Psychiatry 25: 447–456
Pantano P, Caramia F, Pierallini A (1999) The role of MRI in dementia. Ital J Neurol Sci 20: 5250–253
Petrovic P, Kalso E, Petersson KM, Ingvar M (2002) Placebo and opioid analgesia–imaging a shared neuronal network. Science 295: 1737–1740
Pfefferbaum A, Sullivan EV, Hedehus M, Adalsteinsson E, Lim KO, Moseley M (2000) In vivo detection and functional correlates of white matter microstructural disruption in chronic alcoholism. Alcohol Clin Exp Res 24: 1214–1221
Pfefferbaum A, Sullivan EV, Hedehus M, Moseley M, Lim KO (1999) Brain gray and white matter transverse relaxation time in schizophrenia. Psychiatry Res 91: 93–100
Posner MI, Petersen SE, Fox PT, Raichle ME (1988) Localization of cognitive operations in the human brain. Science 240: 1627–1631
Pujol J, Torres L, Deus J, Cardoner N, Pifarre J, Capdevila A, Vallejo J (1999) Functional magnetic resonance imaging study of frontal lobe activation during word generation in obsessive-compulsive disorder. Biol Psychiatry 45: 891–897
Raichle ME, Grubb RL Jr, Gado MH, Eichling JO, Ter-Pogossian MM (1976) Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man. Arch Neurol 33: 523–526
Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ (1994) Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 51: 62–70
Rauch SL, van der Kolk BA, Fisler RE et al. (1996) A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry 53: 380–387
Rauch SL, Whalen PI, Shin LM et al. (2000) Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 47: 769–776
Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95 Suppl 2: S91–117
Rose SE, Chen F, Chalk JB et al. (2000) Loss of connectivity in Alzheimer’s disease: an evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging. J Neurol Neurosurg Psychiatry 69: 528–530
Sandson TA, Felician 0, Edelman RR, Warach S (1999) Diffusion-weighted magnetic resonance imaging in Alzheimer’s disease. Dement Geriatr Cogn Disord 10: 166–171
Sapolsky RM (1996) Why stress is bad for your brain. Science 273: 749–750
Schneider F, Weiss U, Kessler C, Salloum JB, Posse S, Grodd W, Muller-Gartner HW (1998) Differential amygdala activation in schizophrenia during sadness. Schizophr Res 34: 133–142
Schweinsburg BC, Taylor MJ, Alhassoon OM et al. (2001) Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury. Alcohol Clin Exp Res 25: 924–934
Shergill SS, Brammer MJ, Williams SC, Murray RM, McGuire PK (2000) Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. Arch Gen Psychiatry 57: 1033–1038
Shin LM, Kosslyn SM, McNally RJ et al. (1997) Visual imagery and perception in posttraumatic stress disorder. A positron emission tomographic investigation. Arch Gen Psychiatry 54: 233–241
Shulman RG (2001) Functional imaging studies: linking mind and basic neuroscience. Am J Psychiatry 158: 11–20. Die Übersicht von Shulman setzt sich mit den Möglichkeiten and methodischen Grenzen der funktionellen Bildgebung (PET and fMRI) als Schittstelle zur Grundlagenforschung kritisch auseinander. Die Zusammenhänge zwischen den erhobenen Signalen in fMRI and PET, neurophysiologischen Parametern and mentalen Prozessen werden dargestellt, Anwendungsmöglichkeiten für das grundlegende Verständnis neuronaler Prozesse werden aufgezeigt and Zusammenhänge zu den bestehenden Theorien über Verstand und Geist (»Theories of mind«) erörtert.
Singer W (1990) The formation of cooperative cell assemblies in the visual cortex. J Exp Biol 153: 177–197
Soares JC, Krishnan KR, Keshavan MS (1996) Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders. Depression 4: 14–30
Stehling MK, Turner R, Mansfield P (1991) Echo-planar imaging: magnetic resonance imaging in a fraction of a second. Science 254: 43–50. Diese historische wichtige Arbeit der Arbeitsgruppe um Mansfield beschreibt wesentliche technische Grundlagen der modernen fMRI. So wird in die grundlegenden physikalischen Aspekte der (damals noch relativ unbekannten) »Echo Planar Imaging Methode« eingeführt. Darüber hinaus führt die Arbeit sehr anschaulich in die verschiedensten Anwendungsgebiete innerhalb und außerhalb der Hirnforschung ein, die sich aus den Möglichkeiten der hohen Zeitauflösung des Verfahrens ergeben haben.
Volz H, Gaser C, Hager F et al. (1999) Decreased frontal activation in schizophrenics during stimulation with the continuous performance test - a functional magnetic resonance imaging study. Eur Psychiatry 14: 17–24
Volz HR, Riehemann S, Maurer I et al. (2000) Reduced phosphodiesters and high-energy phosphates in the frontal lobe of schizophrenic patients: a (31)P chemical shift spectroscopic-imaging study. Biol Psychiatry 47: 954–961
Wible CG, Kubicki M, Yoo SS et al. (2001) A functional magnetic resonance imaging study of auditory mismatch in schizophrenia. Am J Psychiatry 158: 938–943
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Braus, D.F., Tost, H., Demirakça, T. (2004). Bildgebende Verfahren bei psychischen Störungen. In: Lautenbacher, S., Gauggel, S. (eds) Neuropsychologie psychischer Störungen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08959-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-662-08959-0_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-08960-6
Online ISBN: 978-3-662-08959-0
eBook Packages: Springer Book Archive